2cureX AB
2QE
Company Profile
Business description
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.
Contact
Fruebjergvej 3
CopenhagenDK-2100
DNKT: +45 22115399
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
14
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,166.70 | 8.80 | 0.11% |
| CAC 40 | 8,108.59 | 86.26 | 1.08% |
| DAX 40 | 23,109.79 | 257.13 | 1.13% |
| Dow JONES (US) | 42,481.15 | 102.17 | -0.24% |
| FTSE 100 | 8,663.80 | 25.79 | 0.30% |
| HKSE | 23,344.25 | 561.31 | -2.35% |
| NASDAQ | 18,223.49 | 34.90 | 0.19% |
| Nikkei 225 | 37,780.54 | 172.05 | 0.46% |
| NZX 50 Index | 12,184.51 | 56.30 | 0.46% |
| S&P 500 | 5,762.74 | 4.83 | -0.08% |
| S&P/ASX 200 | 7,942.50 | 5.60 | 0.07% |
| SSE Composite Index | 3,369.98 | 0.05 | -0.00% |